Publication:
Hepatitis-B Seroprevalence Among Children in a Turkish Hospital

dc.contributor.authorCetinkaya, F
dc.contributor.authorGurses, N
dc.contributor.authorOzturk, F
dc.date.accessioned2020-06-21T11:31:48Z
dc.date.available2020-06-21T11:31:48Z
dc.date.issued1995
dc.departmentOMÜen_US
dc.department-tempONDOKUZ MAYIS UNIV,SCH MED,DEPT PEDIAT,SAMSUN,TURKEY --en_US
dc.description.abstractHepatitis B surface antigen (HBsAg) and antibodies to HBsAg (anti-HBs) were examined using enzyme-linked immunosorbent assay methods in 1316 patients from Onkoduz Mayis University Children's Hospital to investigate the epidemiology of hepatitis B in children from our region. The age range was from one month to 16 years. Seroprevalence of HBsAg and anti-HBs was 3.2 and 13.3%, and increased with age. None of the children had received hepatitis B vaccine. Hepatitis B is an important health problem in our region, and all children should be vaccinated.en_US
dc.identifier.doi10.1016/0195-6701(95)90331-3
dc.identifier.endpage219en_US
dc.identifier.issn0195-6701
dc.identifier.issue3en_US
dc.identifier.pmid7615939
dc.identifier.startpage217en_US
dc.identifier.urihttps://doi.org/10.1016/0195-6701(95)90331-3
dc.identifier.urihttps://hdl.handle.net/20.500.12712/9887
dc.identifier.volume29en_US
dc.identifier.wosWOS:A1995QP06800007
dc.language.isoenen_US
dc.publisherW B Saunders Co Ltden_US
dc.relation.journalJournal of Hospital Infectionen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis Ben_US
dc.subjectHBV Surface Antigen (HBsAg)en_US
dc.subjectAntibodies to HBsAgen_US
dc.subjectPediatric Infectionen_US
dc.titleHepatitis-B Seroprevalence Among Children in a Turkish Hospitalen_US
dc.typeNoteen_US
dspace.entity.typePublication

Files